DOI QR코드

DOI QR Code

Sex-specific Associations Between Serum Hemoglobin Levels and the Risk of Cause-specific Death in Korea Using the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS)

  • An, Yoonsuk (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Jang, Jieun (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Lee, Sangjun (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Moon, Sungji (Department of Preventive Medicine, Seoul National University College of Medicine) ;
  • Park, Sue K. (Department of Preventive Medicine, Seoul National University College of Medicine)
  • Received : 2019.06.10
  • Accepted : 2019.10.16
  • Published : 2019.11.29

Abstract

Objectives: The purpose of this study was to determine the associations between blood hemoglobin (Hgb) levels and the risk of death by specific causes. Methods: Using the National Health Insurance Services-National Health Screening Cohort (n=487 643), we classified serum Hgb levels into 6 sex-specific groups. Cox regression analysis was used to analyze the associations between Hgb levels and the risk of cause-specific death. Results: Hgb levels in male population showed a U-shaped, J-shaped, or inverse J-shaped association with the risk of death from ischemic heart disease, acute myocardial infarction, liver cancer, cirrhosis and chronic obstructive pulmonary disease (COPD) (all non-linear p<0.05; hazard ratio [HR]; 95% confidence interval [CI]) for the lowest and the highest Hgb levels for the risk of each cause of death in male population: HR, 1.14; 95% CI, 0.98 to 1.34; HR, 2.87; 95% CI, 1.48 to 5.57; HR, 1.16; 95% CI, 0.96 to 1.40; HR, 3.05; 95% CI, 1.44 to 6.48; HR, 1.36; 95% CI, 1.18 to 1.56; HR, 2.11; 95% CI, 1.05 to 4.26; HR, 3.64; 95% CI, 2.49 to 5.33; HR, 5.97; 95% CI, 1.44 to 24.82; HR, 1.62; 95% CI, 1.14 to 2.30; HR, 3.84; 95% CI, 1.22 to 12.13, respectively), while in female population, high Hgb levels were associated with a lower risk of death from hypertension and a higher risk of death from COPD (overall p<0.05; HR, 1.86; 95% CI, 1.29 to 2.67 for the lowest Hgb levels for hypertension; overall p<0.01, HR, 6.60; 95% CI, 2.37 to 18.14 for the highest Hgb levels for COPD). For the risk of lung cancer death by Hgb levels, a linear negative association was found in male population (overall p<0.01; the lowest Hgb levels, HR, 1.17; 95% CI, 1.05 to 1.33) but an inverse J-shaped association was found in female population (non-linear p=0.01; HR, 1.25; 95% CI, 0.96 to 1.63; HR, 2.58; 95% CI, 1.21 to 5.50). Conclusions: Both low and high Hgb levels were associated with an increased risk of death from various causes, and some diseases showed different patterns according to sex.

Keywords

References

  1. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91(12):2214-2221. https://doi.org/10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
  2. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005;165(19):2214-2220. https://doi.org/10.1001/archinte.165.19.2214
  3. Kalra PR, Greenlaw N, Ferrari R, Ford I, Tardif JC, Tendera M, et al. Hemoglobin and change in hemoglobin status predict mortality, cardiovascular events, and bleeding in stable coronary artery disease. Am J Med 2017;130(6):720-730. https://doi.org/10.1016/j.amjmed.2017.01.002
  4. Zhang YH, Lu Y, Lu H, Zhang MW, Zhou YM, Li XL, et al. Pretreatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer. Mol Clin Oncol 2018;9(1):44-49.
  5. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med 2003;163(12):1400-1404. https://doi.org/10.1001/archinte.163.12.1400
  6. Kimberly WT, Lima FO, O'Connor S, Furie KL. Sex differences and hemoglobin levels in relation to stroke outcomes. Neurology 2013;80(8):719-724. https://doi.org/10.1212/WNL.0b013e31828250ff
  7. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003;34(5):1114-1119. https://doi.org/10.1161/01.STR.0000068410.07397.D7
  8. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005;36(4):809-814. https://doi.org/10.1161/01.STR.0000157662.09551.e5
  9. Murphy WG. The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences. Blood Rev 2014;28(2):41-47. https://doi.org/10.1016/j.blre.2013.12.003
  10. Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 2017;7(9):e016640. https://doi.org/10.1136/bmjopen-2017-016640
  11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352(10):1011-1023. https://doi.org/10.1056/NEJMra041809
  12. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006;107(5):1747-1750. https://doi.org/10.1182/blood-2005-07-3046
  13. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008;60(2):210-241. https://doi.org/10.1124/pr.107.08002
  14. Rayner JC, Best DJ. Unconditional analogues of Cochran-Mantel-Haenszel tests. Aust N Z J Stat 2017;59(4):485-494. https://doi.org/10.1111/anzs.12215
  15. Knafl GJ, Barakat LP, Hanlon AL, Hardie T, Knafl KA, Li Y, et al. Adaptive modeling: an approach for incorporating nonlinearity in regression analyses. Res Nurs Health 2017;40(3):273-282. https://doi.org/10.1002/nur.21786
  16. Kong D, Ibrahim JG, Lee E, Zhu H. FLCRM: functional linear cox regression model. Biometrics 2018;74(1):109-117. https://doi.org/10.1111/biom.12748
  17. Garvin JH. Sex-specific aspects of pediatric hematology and oncology. In: Legato MJ, editor. Principles of gender-specific medicine. 2nd ed. Amsterdam: Elsevier; 2010, p. 51-61.
  18. Jelkmann W. Regulation of erythropoietin production. J Physiol 2011;589(6):1251-1258. https://doi.org/10.1113/jphysiol.2010.195057
  19. Shahani S, Braga-Basaria M, Maggio M, Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest 2009;32(8):704-716. https://doi.org/10.1007/BF03345745
  20. Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000;21(7):515-520. https://doi.org/10.1053/euhj.1999.1699
  21. Stucchi M, Cantoni S, Piccinelli E, Savonitto S, Morici N. Anemia and acute coronary syndrome: current perspectives. Vasc Health Risk Manag 2018;14:109-118. https://doi.org/10.2147/VHRM.S140951
  22. Kiyohara C, Ohno Y. Sex differences in lung cancer susceptibility: a review. Gend Med 2010;7(5):381-401. https://doi.org/10.1016/j.genm.2010.10.002
  23. Shimada S, Hasegawa K, Wada H, Terashima S, Satoh-Asahara N, Yamakage H, et al. High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J 2011;75(1):185-189. https://doi.org/10.1253/circj.CJ-10-0335
  24. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. Am Heart J 1994;127(3):674-682. https://doi.org/10.1016/0002-8703(94)90679-3
  25. Shin HY, Lee JY, Kim JE, Lee S, Youn H, Kim H, et al. Cause-ofdeath statistics in 2016 in the Republic of Korea. J Korean Med Assoc 2018;61(9):573-584. https://doi.org/10.5124/jkma.2018.61.9.573
  26. Korean Statistical Information Service. National estimate population 2017 [cited 2019 Nov 4]. Available from: http://kosis.kr/publication/publicationThema.do?pubcode=CC (Korean).

Cited by

  1. 1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints vol.75, 2019, https://doi.org/10.1016/j.ebiom.2021.103764